Summer Haven Investment Management, LLC Collegium Pharmaceutical, Inc Transaction History
Summer Haven Investment Management, LLC
- $156 Million
- Q4 2024
A detailed history of Summer Haven Investment Management, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Summer Haven Investment Management, LLC holds 23,906 shares of COLL stock, worth $797,265. This represents 0.44% of its overall portfolio holdings.
Number of Shares
23,906
Previous 23,906
-0.0%
Holding current value
$797,265
Previous $923,000
25.89%
% of portfolio
0.44%
Previous 0.59%
Shares
7 transactions
Others Institutions Holding COLL
# of Institutions
250Shares Held
36.7MCall Options Held
100KPut Options Held
21.1K-
Black Rock Inc. New York, NY5.79MShares$193 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$87.9 Million1.79% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.59MShares$86.4 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$78.3 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$55.2 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.14B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...